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Abstract
Background: High-risk human papillomavirus (hrHPV) infections are causally related to cervical cancer
development. The additional (epi)genetic alterations driving malignant transformation of hrHPV-infected cells
however, are not yet fully elucidated. In this study we experimentally assessed the role of the PI3-kinase pathway
and its regulator PIK3CA, which is frequently altered in cervical cancer, in HPV-induced transformation.
Methods: Cervical carcinomas and ectocervical controls were assessed for PIK3CA mRNA and protein expression by
quantitative RT-PCR and immunohistochemical staining, respectively. A longitudinal in vitro model system of hrHPV-
transfected keratinocytes, representing the immortal and anchorage independent phenotype, was assayed for PI3-
kinase activation and function using chemical pathway inhibition i.e. LY294002 treatment, and PIK3CA RNA
interference. Phenotypes examined included cellular viability, migration, anchorage independent growth and
differentiation. mRNA expression of hTERT and HPV16 E6E7 were studied using quantitative RT-PCR and Northern
blotting.
Results: Cervical carcinomas showed significant overexpression of PIK3CA compared to controls. During HPV-
induced transformation in vitro, expression of the catalytic subunit PIK3CA as well as activation of downstream
effector PKB/AKT progressively increased in parallel. Inhibition of PI3-kinase signalling in HPV16-transfected
keratinocytes by chemical interference or siRNA-mediated silencing of PIK3CA resulted in a decreased
phosphorylation of PKB/AKT. Moreover, blockage of PI3-kinase resulted in reduced cellular viability, migration, and
anchorage independent growth. These properties were accompanied with a downregulation of HPV16E7 and
hTERT mRNA expression. In organotypic raft cultures of HPV16- and HPV18-immortalized cells, phosphorylated PKB/
AKT was primarily seen in differentiated cells staining positive for cytokeratin 10 (CK10). Upon PI3-kinase signalling
inhibition, there was a severe impairment in epithelial tissue development as well as a dramatic reduction in p-
PKB/AKT and CK10.
Conclusion: The present data indicate that activation of the PI3-kinase/PKB/AKT pathway through PIK3CA regulates
various transformed phenotypes as well as growth and differentiation of HPV-immortalized cells and may therefore
play a pivotal role in HPV-induced carcinogenesis.
Background
It has been well established that high-risk human papil-
lomavirus (hrHPV) infections are causally related to cer-
vical cancer development [1]. While the two most
potent viral oncogenes E6 and E7 are necessary for the
initiation and maintenance of cellular proliferation [2,3],
their expression is not sufficient for full transformation
of epithelial cells. Hence, there are extensive efforts
towards identifying additionally required host cell
events. Chromosomal analysis has revealed that a gain
of chromosome 3q is the most common event in the
development of cervical squamous cell carcinoma (SCC)
[4-6]. In fact, a gain of chromosome 3q was found in all
SCC previously analysed by microarray CGH [6]. Candi-
date oncogenes on chromosome 3q include the gene
encoding p110a, the active subunit phosphatidylinositol
3-kinase catalytic alpha (PIK3CA) of class I PI3-kinase.
Upon activation, PI3-kinase initiates events leading to
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downstream signalling proteins involved in survival and
cell growth. Indeed, deregulation of the PI3-kinase path-
way is common in many human malignancies [7]. In
cervical carcinomas, an increased copy number of
PIK3CA was positively correlated with an increase in
phosphorylated PKB/AKT, one of the downstream effec-
tors [8]. Additionally, the level of p-PKB/AKT expres-
sion increased proportional to the histopathological
grade of (pre)malignant cervical diseases [9,10].
Although it has been found that HPV16E7 can activate
PKB/AKT in differentiating cells [10], the relevance of
PI3-kinase signalling in the process of cervical cancer
development following a transforming hrHPV infection
remains to be experimentally explored. Moreover, no
functional studies on the specific role of PIK3CA in cer-
vical carcinogenesis have yet been performed.
Previously we have shown that in vitro transformation
of primary keratinocytes mediated by full-length hrHPV
was accompanied with a gain of chromosome 3q in
immortalized descendants [6]. This model system of
HPV-transformed keratinocytes therefore provides inter-
esting and useful source material to study the potential
functional role of PI3-kinase for the various transformed
phenotypes. In the present study we analysed PIK3CA
expression in cervical squamous cell carcinomas. We
also performed functional analyses of the contribution
of PI3-kinase signalling, and specifically PIK3CA, to
hrHPV-mediated transformation in vitro.
Methods
Cell culture, LY294002 treatment and transfection
Primary human foreskin keratinocytes, HPV16 and
HPV18-immortalized keratinocyte cell lines (FK16A and
FK18A) as well as HPV16E6E7 containing keratinocytes
were cultured as described previously [11]. The latter
cells were generated by transduction of primary human
foreskin keratinocytes with the retroviral vector
pLZRSneo containing HPV16E6E7, as described pre-
viously [12].
FK16A cells between passages 45 and 62 represented
immortal and anchorage dependent cells and FK16A
cells between passages 99 and 189 represented ancho-
rage independent cells [11]. Prior to LY294002 (10 μM
and 20 μM) (Cell Signaling Technology, Beverly, USA)
or DMSO treatment, cells were starved overnight to
ensure similar phosphorylation status. A pool of 4
siRNA sequences targeting PIK3CA (cat#L-003018-00-
0005, Dharmacon, Lafayette, USA) was transfected using
Dharmafect reagent 2 (Dharmacon) according to the
manufacturers protocol. Pools of 4 non-targeting siR-
NAs (cat#D-001810-10-05) and PLK1 specific siRNAs
(cat#L-003290-00-0005) were used as negative and posi-
tive controls, respectively. The use of a non-targeting
siRNA pool ensures control for off-target effects. Trans-
fection of cDNA encoding for myristoylated PIK3CA
[13] Addgene, Cambridge, USA) and cotransfections
with HPV16-URR luciferase constructs into FK16A cells
were performed using Effectene (Qiagen, Hilden, Ger-
many) according to instructions. Firefly luciferase and
Renilla luciferase were measured using Dual Luciferase
assay (Promega, Wisconsin, USA).
Clinical material
All tissue specimens were collected during the course of
routine clinical practice at the Department of Obstetrics
and Gynecology at the VU University medical center.
Normal epithelial control samples were obtained from
histologically normal frozen biopsies of non-cancer
patients undergoing hysterectomy. This study followed
the ethical guidelines of the Institutional Review Board
of the VU University medical center.
RNA isolation, RT-PCR and Northern Blotting
Isolation of mRNA from cell lines was performed using
RNA-B reagent (Tel-Test, Friendswood, USA) and
DNase treated (Promega) prior to cDNA synthesis using
specific reverse primers (see below). Total RNA from
micro-dissected frozen biopsies of cervical SCCs and
normal ectocervical controls was isolated using Trizol
reagent (Invitrogen Life Technologies, Breda, The Neth-
erlands) as described before [14]. Quantitative RT-PCR
was performed as described previously [15] using the
following primers for PIK3CA forward 5’-CCTGATCT
TCCTCGTGCTGCTC-3’ and reverse 5’- ATGCCAAT
GGACAGTGTTCCTCTT -3’ using SYBR Green PCR
Master Mix (Applied Biosystems, Carlsbad, CA, USA).
And for hTERT forward 5’-CACGCGAAAACCTTCCTCA
-3’, reverse 5’-CAAGTTCACCACGCAGCC-3’ and the
probe FAM-5’-CTCAGGGACACCTCGGACCAGGGT
-3’-TAMRA using Universal PCR Master Mix (Applied
Biosystems). To correct for RNA quality and input, we per-
formed RT-PCR for the housekeeping gene snRNP as
described before in cell line experiments [16]. For quantifi-
cation, a standard curve was established using serial
dilutions of cervical cancer cell line cDNA. To determine
HPV16E7 mRNA expression LightCycler real-time
PCR assays were applied as described before [17,18] as well
as Northern Blotting for HPV16. Total RNA was separated
on a 1% agarose gel, blotted on nylon membranes
(GeneScreen, PerkinElmer Life Sciences, Waltham, USA)
and hybridized with a radioactive labelled full length
HPV16 probe.
Immunoblotting
Antibodies against total (cat#9272) or phosphorylated
forms of PKB/AKT (cat#4058), PIK3CA (cat#4255) and
loading control beta-actin (cat#4967) (all 1:1000 from
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manufacturers instructions. Membranes were incubated
with the appropriate horseradish peroxidase-conjugated
secondary antibodies and the levels of corresponding
proteins were visualized using SuperSignal West Dura
Extended Duration Substrate (Pierce).
Immunohistochemical staining and immunofluorescence
assays
Immunohistochemical staining was performed using 4
μm sections which were deparaffinised, rehydrated and
microwave-treated (800W) for 10 min in Tris buffer
(pH9), followed by incubation for 30 min in 3% H2O2 in
methanol. Antibody incubation with PIK3CA (cat#4249
Cell Signaling 1:200) was performed overnight at 4°C
and for detection the EnVision horseradish peroxidase
system (Dako, Heverlee, Belgium) was used.
For immunofluorescence, 4 μm sections were rehy-
drated, treated with 10 mM citrate, pH 6.0 at 95°C for
10 min and allowed to cool to room temperature over
20 min. Slides were then treated with 3% H2O2 in water
and blocked in 1XPBS containing 10% goat serum. P-
PKB/AKT and Ki-67 were detected by sequential prob-
ing with respective antibodies because both were raised
in rabbit. P-PKB/AKT was probed with rabbit monoclo-
nal antibody (cat#2118-1, Epitomics Inc, 1:100 dilution)
and detected by fluorescine-conjugated tyramide
(NEL701001, PerkinElmer Life Science, USA) as per the
manufacturers direction. Subsequently, Ki-67 was
probed with rabbit monoclonal antibody (ab16667,
Abcam, 1:100 dilution) and detected by Alexa Fluor 555
conjugated anti-rabbit IgG (cat#A21429, Invitrogen-
Molecular Probes, USA.) as per the manufacturers pro-
tocol. P-PKB/AKT and CK10 localization was detected
by concurrent probing with respective primary antibo-
dies as they were raised in different species. Raft sec-
tions were treated with rabbit anti p-PKB/AKT
(described above) and mouse monoclonal anti-CK10
(cat#ab1421, 1:150 dilution, Abcam, Cambridge, USA).
Anti-CK10 was detected with Alexa Fluor 555 conju-
gated goat anti-mouse IgG (cat#A21424, Invitrogen-
Molecular Probes, USA). Finally slides were mounted
with DAPI containing media (VECTASHIELD, H1200,
Vector Laboratories, USA), viewed under Olympus
AX70 microscope fitted with Chroma filters. Photomi-
crographs were captured by Axiovision camera at 20×
magnifications of objective and finally processed with
Photoshop CS2 (Adobe) for documentation.
Cell Viability, Migration, Anchorage Independent Growth
Cell viability was assessed by MTT (3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide) dye reduc-
tion (ICN Biomedicals Inc, USA). Cells were seeded in
triplicate wells in 96-wells plates, transfected or starved
overnight followed by LY294002 treatment and grown
for 5 days. Control conditions were set to 100%.
For cellular migration assays cells were plated at high
confluence and uniformly scratched to create a cell-free
gap. After 24-48 hours in serum-free keratinocyte
growth medium, plates were examined and photo-
graphed to asses the migration of neighbouring cells
into the gap.
To examine anchorage independent growth under the
different conditions 5000 cells of each condition were
plated in semi-solid agarose (as described previously
[19]). After 3 weeks colonies larger than ~50 cells were
counted and pictures taken.
Organotypic raft cultures
The HPV containing keratinocytes were grown as
epithelial raft tissues as described previously [20]. For all
conditions duplicate rafts were developed. Transfections
with siRNAs were carried out the day before seeding on
the collagen beds. Inhibitor treatment was started after
seeding and continued throughout the 9 days of cultur-
ing at the liquid-air interface. After harvesting, the raft
tissues were fixed in formalin and embedded in paraffin.
For histological examination, 4 μm sections were stained
with hematoxylin and eosin.
Statistical analysis
All statistical analyses were carried out using the T-test
in the SPSS software package (SPSS 15.0, Chicago,
USA).
Results
Increased PIK3CA expression in cervical carcinomas
To investigate the relevance of PI3-kinase pathway acti-
vation in cervical carcinogenesis, mRNA and protein
expression levels of the catalytic subunit PIK3CA were
examined. As can be seen in Figure 1A messenger RNA
levels for PIK3CA were significantly higher in SCC (n =
12) as compared to normal ectocervical controls (n =
10) (p = 0.005). All cervical carcinomas were previously
analysed with arrayCGH and contained a gain of chro-
mosome 3q [6], suggesting that elevated mRNA expres-
sion may be related to increased genomic content. A
subset of cervical carcinomas was also analysed for
PIK3CA protein expression using immunohistochemis-
try. Diffuse PIK3CA protein expression was observed in
the tumor fields, whereas the upper strata were negative
in adjacent normal cervical epithelium (Figure 1B).
The PI3-kinase pathway becomes increasingly activated
during hrHPV-induced transformation in vitro
To examine whether the PI3-kinase pathway is relevant
for HPV-mediated transformation in vitro,w em a d eu s e
of our model system consisting of primary keratinocytes
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model consists of successive stages of transformation,
including immortalization and anchorage-independent
growth. The immortal cells have bypassed the senes-
cence and crisis barriers that mark the end of the repli-
cative and extended lifespan, respectively, and display
increased telomerase activity [11]. At this stage, the cells
also possess a gain of chromosome 3q [6]. Upon further
passaging the immortal cells acquired an anchorage-
independent phenotype [19].
HPV16-transfected keratinocytes (FK16A) representing
these two different stages of transformation were ana-
lysed for PIK3CA mRNA and protein expression. One
of the downstream targets of PIK3CA activation, the
phosphorylated PKB/AKT, along with total PKB/AKT
were also analysed. FK16A cells showed an increase in
PIK3CA mRNA expression with progression from
immortal to an anchorage-independent phenotype
(Figure 2A), which was associated with a slight elevation
in PIK3CA protein expression (Figure 2B). During
passaging a stronger increase in phosphorylation of
PKB/AKT was seen (Figure 2B), indicative of a progres-
sive activation PI3-kinase signalling. Analysis of HPV18
transfected keratinocytes derived from the same donor
also revealed an increase in phosphorylated PKB/AKT
with passaging (Additional File 1, Figure S1). Similarly,
HPV16E6E7 containing keratinocytes obtained from a
second donor displayed increasing p-PKB/AKT levels
with passaging (Additional File 2, Figure S2). The latter
cells also showed a slight increase in PIK3CA protein
expression at later passage. These data indicate that PI3-
kinase signalling becomes progressively activated during
HPV-induced transformation and is donor and hrHPV
type independent.
Phosphorylation and activation of PKB/AKT is a result
of upstream signalling events. Hence, we proceeded to
determine whether we could influence PKB/AKT phos-
phorylation by modulating PI3-kinase activity in our
model system. Different passages of FK16A cells were
treated with the chemical PI3-kinase inhibitor LY294002,
which fits in the ATP binding pocket of the catalytic sub-
unit PIK3CA [21]. LY294002 treatment resulted in
reduction of the levels of phosphorylated PKB/AKT at
all passages, while total PKB/AKT remained the same
(Figure 2B). These results indicate that phosphorylation
of PKB/AKT in these cells relies at least in part on the
activity of PI3-kinase signalling.
PI3-kinase signalling is functionally involved in hrHPV-
induced transformation in vitro
To examine the biological role of the PI3-kinase path-
way in our cell lines, we determined the functional con-
sequences of LY294002 treatment. Figure 3A illustrates
that for both immortal and anchorage-independent pas-
sages of FK16A incubation with LY294002 resulted in a
statistically significant reduction in the number of viable
cells using a viability assay (MTT) (p = 0.001 for each
passage). Another important feature of transformation is
the migratory capacity of cells. Figure 3B shows that,
upon wound induction, HPV16-tranformed keratinocytes
migrated and closed the wound after 2 days. In contrast,
chemical inhibition of PI3-kinase in these cells reduced
their migratory capacity, as cells were unable to close the
wound. Lastly, we examined anchorage-independent
growth. At a concentration of 10 μM of the inhibitor, col-
ony formation was significantly inhibited compared to
mock treated controls (p = 0.003) and decreased further
at a concentration of 20 μM (p = 0.001) (Figure 3C and
B
*
A
Figure 1 PIK3CA expression.( A) mRNA expression levels of PIK3CA in SCCs compared to normal ectocervical epithelium determined by
quantitative RT-PCR. The upper and lower boundaries of the boxes represent the 75th to 25th percentile, bars within the boxes represent the
median value. Whiskers represent the minimum and maximum values. (B) Representative pictures of immunostainings for PIK3CA on a cervical
carcinoma specimen (left) and normal cervical epithelium (right) (20× magnification).
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signalling is functionally relevant for the transformed
phenotypes of hrHPV-immortalized cells.
The catalytic subunit PIK3CA is essential for HPV-
mediated transformation
O u rf i n d i n g ss t r o n g l ys u g g e s t e dar o l eo fP I K 3 C Ai n
HPV-mediated transformation. Since LY294002 is a uni-
versal PI3-kinase inhibitor affecting the different PI3-
kinase classes to varied extents, we next employed RNA
interference to examine PIK3CA specifically. A pool of
specific siRNAs was used to silence PIK3CA expression
in anchorage independent FK16A cells. Non-targeting
siRNAs were used to control for off-target effects. The
reduction of PIK3CA expression was confirmed by Wes-
tern blotting (Figure 4A). PIK3CA silencing strongly
inhibited PI3-kinase signalling as reflected by reduced
phosphorylation of PKB/AKT without reduction of total
PKB/AKT (Figure 4A).
Following PIK3CA specific siRNA transfection cells
were seeded for the functional tests described above.
Similar to LY294002 treatment, siRNA-mediated
PIK3CA knockdown significantly reduced the number of
viable FK16A cells (p = 0.0005) compared to transfection
with a pool of non-targeting siRNAs (Figure 4B). Knock-
down of PLK1, inducing cell death and used as a positive
control, also resulted in a significant reduction of viable
cells (p = 0.0003). FK16A cells transfected with siRNAs
targeting PIK3CA also lost their migratory capacity and
were unable to close the wound (Figure 4C). Primary
human foreskin keratinocytes, included as controls, dis-
played a minor reduction in migratory capacity upon
PIK3CA silencing (Additional File 3, Figure S3), in con-
cordance with the lower level of PIK3CA mRNA in these
cells (Figure 2A). Lastly, anchorage-independent growth
was also affected by PIK3CA knockdown to a similar
extent as after treatment with 10 μM LY294002 (p =
0.05) (Figure 4D). Taken together, these results show that
PIK3CA is relevant for the oncogenic properties of HPV-
mediated transformation.
To substantiate our hypothesis that PIK3CA is an
important mediator of PI3-kinase signalling in HPV-trans-
formed cells, we examined the effect of PIK3CA over-acti-
vation. This was achieved by transfection of anchorage
independent FK16A cells with cDNA encoding myristoy-
lated PIK3CA in which a coding sequence for the myris-
toylation domain of c-Src is fused in-frame with the
PIK3CA coding sequence [13]. The amino-terminal myris-
toylation modification ensures membrane targeting of
PIK3CA, allowing PIP3 production without the otherwise
required receptor activation. Figure 5A shows that trans-
fection of PIK3CA cDNA resulted in increased levels of
PIK3CA protein and also enhanced levels of p-PKB/AKT.
After treatment with LY294002, levels of p-PKB/AKT
reverted, whereas levels of PIK3CA remained elevated.
Viable cells increased significantly in FK16A cultures with
ectopically activated PIK3CA when compared with
untransfected cells (p = 0.04). This effect was reversed by
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Figure 2 Expression of PIK3CA, p-PKB/AKT and total PKB/AKT expression in FK16A cells. (A) mRNA expression for PIK3CA in primary
keratinocytes (p4), immortal FK16A cells (p38) and anchorage independent FK16A cells (p99). Shown are PIK3CA levels relative to snRNP. (B)
Protein expression of PIK3CA, p-PKB/AKT, total PKB/AKT and actin in FK16A cells at immortal (p50) and anchorage independent (p121) stage.
Second lanes for each cell line represent samples treated with 20 μM LY294002 (Ly) to inhibit PI3-kinase signalling. P: passage.
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ings further strengthen the notion of a role of PIK3CA
and PI3-kinase signalling in HPV-containing cells.
PI3-kinase signalling is involved in transcriptional
regulation of HPV
In search of an explanation for the altered growth proper-
ties of the HPV16 containing keratinocytes upon manipu-
lation of the PI3-kinase pathway, HPV16 expression was
examined. Figure 6A shows that there was only a slight
variation with increased passaging in HPV16 mRNA
expression. After PI3-kinase inhibition in anchorage
independent cells however, we found that HPV16 mRNA
expression was strongly reduced as can be seen in the
Northern Blot results in Figure 6B. Further quantification
by real time RT-PCR revealed that HPV16E7 mRNA levels
were significantly reduced after chemical inhibition to
about half of the original expression at a concentration of
20 μM LY294002 (p = 0.04) (Figure 6C). To analyze
further downstream effects of reduced HPV expression
transcription of hTERT was monitored, which is known to
be stimulated by E6 expression [22]. Cells in which
PIK3CA was silenced and HPV mRNA expression was
reduced also displayed a trend towards reduced hTERT
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Figure 3 The functional consequences of silencing PI3-kinase signalling using the chemical inhibitor LY294002 (Ly) in FK16A cells. (A)
Cell viability as measured 4 days post-treatment using an MTT assay. Appropriate controls were set to 100%. Immortal (p51) and anchorage
independent (p127) FK16A cells were treated with the PI3-kinase inhibitor LY294002. (B) Representative pictures of migration assay performed
with anchorage independent FK16A cells (p123). Upper panel: mock treated cells, lower panel: cells treated with 20 μM of the PI3-kinase
inhibitor LY294002. Pictures were taken immediately after scratch induction and 48 hours post-induction. (C) Late passage FK16A cells (p119)
were seeded in semi-solid agarose in the presence of the PI3-kinase inhibitor. After 3 weeks in culture colonies were quantified relative to the
appropriate controls, set to 100%. * Indicates a statistical significant difference. (D) Representative pictures of anchorage independent growth
results upon various LY294002 concentrations. P: passage.
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expression levels in immortal and anchorage independent
cells were comparable, while PIK3CA expression and PI3-
kinase activity were increased in anchorage independent
cells, the results shown in Figure 6B-6D suggest a func-
tional cross-talk between PI3-kinase and maintenance of
HPV oncogene expression.
PI3-kinase signalling is essential for growth and
differentiation of HPV-immortalized cells in organotypic
cultures
Culturing human keratinocytes on organotypic raft
mimics epithelial stratification and differentiation into
various strata, whereby PI3-kinase signalling is known to
play a role [10,23-25]. We have previously shown that
differentiation is disturbed in HPV16- and HPV18-
immortalized keratinocytes, revealing phenotypes remi-
niscent of HPV-induced dysplastic lesions [20]. Thus,
we next studied the roles of PI3-kinase signalling in
growth and differentiation of these HPV-immortalized
keratinocytes in organotypic raft cultures. FK16A cells
displayed a severely dysplastic morphology on epithelial
raft cultures, whereas an HPV18 immortalized cell line,
FK18A, appeared less dysplastic and maintained term-
inal differentiation [20]. These different attributes permit
a comparison of cell growth and differentiation upon
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Figure 4 The effect of siRNA mediated silencing of PIK3CA on protein expression, cell viability, migration and anchorage independent
growth of FK16A cells. (A) Protein expression of PIK3CA, p-PKB/AKT, total PKB/AKT and actin in FK16A cells (p122) transfected with non-
targeting control siRNAs and siRNAs targeting PIK3CA. (B) Cell viability as measured 4 days post-treatment using an MTT assay. Anchorage
independent (p119) FK16A cells were transfected with non-targeting control siRNAs, siRNAs targeting PIK3CA. Silencing PLK1 served as a positive
control. Appropriate controls were set to 100%. * Indicates a statistical significant difference. (C) Representative pictures of migration assay
performed with anchorage independent FK16A cells (p125). Upper panel: cells transfected with non targeting siRNA pool, lower panel: cells
transfected with siRNA pool against PIK3CA. Pictures were taken immediately after scratch induction and 48 hours post-induction. (D) Late
passage FK16A cells (p119) were seeded in semi-solid agarose following transfection with non-targeting control siRNAs or siRNAs targeting
PIK3CA. After 3 weeks in culture colonies were quantified relative to the appropriate controls, set to 100%. * Indicates a statistical significant
difference. P: passage.
Henken et al. Molecular Cancer 2011, 10:71
http://www.molecular-cancer.com/content/10/1/71
Page 7 of 13modulating PI3-kinase. As described above, FK18A cells
also exhibited increased levels of phosphorylated PKB/
AKT with passaging (Additional File 1, Figure S1).
Epithelial raft culturing of immortal FK16A cells in
the presence of the PI3-kinase inhibitor or after silen-
cing PIK3CA using siRNAs, hampered epithelial raft
culture development compared to mock treated cells or
cells treated with non-targeting siRNAs (Figure 7A).
Particularly upon LY294002 treatment the epithelium
was very thin, whereas transfection of PIK3CA-siRNAs
had less effect on epithelial growth. These observations
suggest that PIK3CA plays a role in the growth of these
cells and that chemical inhibition of PI3-kinase most
likely has additional effects besides PKB/AKT inactiva-
tion. Similarly, raft culture growth of FK18A cells was
strongly reduced upon chemical inhibition of PI3-kinase.
No clear histological difference was seen in FK18A cells
over-expressing activated PIK3CA (Figure 7A). Analysis
of primary human foreskin keratinocytes showed no
effect on growth on organotypic culture upon PIK3CA
silencing (see Additional File 4, Figure S4).
To further assess the relation between phosphorylated
PKB/AKT, cell proliferation and squamous differentia-
tion, we performed double indirect immunostainings for
p-PKB/AKT and Ki-67, a proliferation marker, or cyto-
keratin 10 (CK10), a differentiation marker.
As shown in Figure 7B, in raft cultures of FK16A cells,
the p-PKB/AKT signals were primarily detected in the
cytoplasm, while Ki-67 was restricted to the nucleus.
Both were detected stochastically throughout most of
the epithelium. In the FK18A raft cultures, while Ki-67-
positive cells were found in all cell strata, the p-PBK/
AKT signal was primarily detected in the upper most
differentiated strata. Interestingly, the two signals rarely
co-localized to the same cells.
After chemical inhibition of PI3-kinase, a fraction of
the remaining epithelial cells were positive for Ki-67
despite the fact that phosphorylated PKB/AKT was
strongly reduced or nearly abolished. In the presence of
siRNAs targeting PIK3CA, the p-PKB/AKT signals in
FK16A raft cultures were also greatly reduced while Ki-
67 signals were not altered. The non-targeting siRNAs
had no effect on either. Upon ectopic expression of acti-
vated PIK3CA, more cells in the upper strata of the
FK18A raft cultures were positive for p-PKB/AKT while
the signals of Ki-67 appeared unchanged.
Figure 7C shows that, in both cell lines, differentiation
marker CK10 was positive from the suprabasal layers
upwards. Consistent with the high dysplastic histology
(Figure 7A), CK10 expression was patchy in the FK16A
raft cultures with packets of CK10-negative cells,
whereas the signals were much more uniformly detected
across the FK18A cultures (Figure 7C). After chemical
inhibition of PI3-kinase signalling in FK16A and FK18A
cultures, not only p-PBK/AKT was largely abolished, but
also the fraction of CK10-positve cells and signal
strengths were both greatly reduced, especially in
FK16A cultures. Similarly, in the siPIK3CA-treated
FK16A cultures, p-PKB/AKT was virtually abrogated
while CK10 signals were greatly reduced. In contrast,
the non-targeting siRNAs had no effect on either signal.
These results strongly suggest that differentiation was
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Page 8 of 13largely abolished upon reduction of p-PKB/AKT.
Despite an increased phophorylated PKB/AKT staining
in FK18A cells overexpressing PIK3CA, CK10 staining
patterns were similar to the non-transfected controls,
because these cells were already strongly positive for
CK10. These data confirm that PI3-kinase signalling is
important for regulating differentiation of HPV-immor-
talized cells.
Discussion
The PI3-kinase/PKB/AKT signalling pathway affects a
wide variety of cellular characteristics such as prolifera-
tion, differentiation and cell survival and is often altered
in many human malignancies [7]. In cervical cancer, a
gain of the long arm of chromosome 3, where PIK3CA
is located, is often described and suggested to be a com-
pulsory second hit for malignant transformation follow-
ing an hrHPV infection [4,6]. However, data is scarce on
the biological effects of altered PIK3CA expression and
PI3-kinase signalling in cervical carcinogenesis.
In the present study we showed that mRNA expression
of the catalytic subunit PIK3CA was significantly upregu-
lated in cervical SCC. In our previous studies using
arrayCGH, up to 100% of cervical SCC were shown to
contain additional copies of chromosome 3q [6]. Addition-
ally, low levels PIK3CA amplifications were found in 40%-
74% of cervical carcinomas [5,8,26]. Bertelsen et al showed
that an increase in PIK3CA copy numbers (more than 3
copies) was significantly correlated to elevated p-PKB/
AKT expression in cervical SCC and high-grade precursor
lesions [8]. Also, other studies reported an increase in p-
PKB/AKT staining with increase of histopathological
grade of cervical disease [9,10].
Functionally, we showed that PIK3CA and concomi-
tant PI3-kinase signalling is involved in the different
stages of HPV-mediated transformation in vitro.
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Page 9 of 13Modulating PI3-kinase activity in HPV transfected kera-
tinocytes affected proliferation, migration, anchorage
independent growth, and epithelial growth and differen-
tiation in organotypic cultures. These data are consistent
with previous reports using different cellular systems.
For instance, in ovarian cancer cell lines PI3-kinase
pathway inhibition with LY294002 resulted in reduced
proliferation via cell cycle arrest in G1 [27] or induction
of apoptosis [28]. Proliferation measured by cell number
and [
3H]-Thymidine incorporation was also reduced in
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Page 10 of 13rat intestinal epithelial cells as a result of LY294002
treatment [29]. Furthermore, the involvement of PI3-
kinase in colony formation has been shown in mammary
epithelial cells where overexpression of PIK3CA
increased colony formation while a dominant negative
form of PIK3R1 (p85) lacking the PIK3CA binding
domain repressed colony formation [30]. This latter
study also showed that, although PKB/AKT is the main
effector of PI3-kinase, PKB/AKT activation cannot sub-
stitute PI3-kinase signalling.
Functional studies in cervical cells are restricted to the
common hrHPV positive cervical cancer cell lines such
as SiHa, HeLa and CaSki and did not include the expli-
cit analysis of PIK3CA as a candidate oncogene. Treat-
ment of SiHa with the PI3-kinase inhibitor LY294002
led to reduced proliferation and increased apoptotic
DNA fragments [5]. For HeLa and CaSki the reduction
in proliferation upon LY294002 treatment was shown to
be independent of apoptosis, though did sensitize the
cells to radiation [31].
None of the previous studies on cancer cells have had
the benefit of a longitudinal characterization as is
afforded by our in vitro model system, which mimics
the different stages of cervical carcinogenesis. We were
able to show a progressive upregulation of PI3-kinase
signalling during HPV-induced transformation by using
the elevation of p-PKB/AKT as a reporter. Indeed, p-
PBK/AKT was elevated in anchorage independent cells
relative to HPV-immortalized cells. The expression
levels of both PIK3CA and especially p-PKB/AKT in the
latter cells were increased compared to primary kerati-
nocytes (data not shown). This increased signalling
functionally correlated with multiple attributes of trans-
formed cells, such as cell growth, migration, and ancho-
rage independent growth (Figure 3). The fact that
specific silencing of PIK3CA using RNA interference
affected each of the same transformed phenotypes in a
negative manner, while PIK3CA overexpression
increased proliferation (Figures 4 and 5) substantiates its
function as an oncogene in cervical carcinogenesis, as
has been suggested in previous studies [5,8,26].
Remarkably, our data also suggest a feedback effect in
which PI3-kinase regulates HPV oncogene expression.
HPV16 mRNA expression and hTERT mRNA were
decreased after inhibition of PI3-kinase signalling
(Figure 6). The downregulation of hTERT mRNA may
be a direct result of reduced HPV expression, as E6 acti-
vates hTERT transcription [22]. Thus, the reciprocal
regulation between PIK3CA/PI3-kinase and viral onco-
gene expression acts in concert in maintaining the
transformed phenotypes [32-34]. However, it is presently
unknown whether the phenotypical effects of PI3-kinase
inhibition seen in our model system reflect a direct con-
sequence of E6/E7 repression or vice versa.
It has been shown that the oncoprotein E7 is able to
activate PKB/AKT, which appeared to be dependent on
its ability to bind and inactivate Rb gene family proteins
[10,35]. E7 may also maintain PKB/AKT in an active
state, by binding and sequestering a known binding
partner, the phosphatase PP2A, thereby inhibiting
dephosphorylation of p-PKB/AKT [36]. Active PKB/
AKT is also known to activate MDM2, enhancing p53
degradation and elevating CDKs leading to pRb inactiva-
tion, further enhancing the established E6/E7 effect on
p53 and pRb function [37,38]. Moreover, activation of
PKB/AKT by PI3-kinase can inhibit nuclear localization
of p27kip1 and p21cip by phosphorylating the nuclear
localization signal and hereby preventing nuclear trans-
port and inducing proliferation, both of which are also
affected by E7 overexpression [35,39]. Here we show
that besides the reported effect of HPVE7 on PI3-kinase
activity, there is also a feed-back effect in that PI3-
kinase can regulate HPV oncogene expression. From the
present data it becomes clear that both mechanisms act
in concert as the increased PI3-kinase activity appears
essential for maintaining HPV oncogene expression. The
need for a strict regulation of HPV expression, as also
implicated in our previous study [40], suggests that yet
other transformation-inducing host cell alterations con-
tribute to the regulated expression of HPVE6/E7 as well
as PI3-kinase signalling activity.
Organotypic raft cultures mimic a natural environ-
ment to evaluate the role of PI3-kinase signalling in the
growth and differentiation of keratinocytes. Phosphory-
lation of PKB/AKT appeared to be tightly linked to dif-
ferentiation, which is in agreement with a previous
report showing upregulation of phosphorylated PKB/
AKT in organotypic raft cultures of HPV16 expressing
keratinocytes [10]. Inhibiting PI3-kinase signalling by
chemical inhibition and PIK3CA siRNA-mediated silen-
cing during raft formation led to a dramatic reduction
in p-PKB/AKT and severely hampered epithelial cell
growth in both HPV16- and HPV18 immortalized cells
(Figure 7). Proliferation marker Ki-67 remained detect-
able in residual epithelial cells, while differentiation mar-
ker CK10 was dramatically reduced. These results
indicate that PIK3CA regulated p-PKB/AKT expression
is important in squamous differentiation. This conclu-
sion is in accordance with a previous report showing
that mouse keratinocytes with active PKB/AKT have
higher levels of differentiation markers Keratin 1, filag-
grin and loricrin. Moreover, inhibition of PI3-kinase
resulted in the specific death of differentiating keratino-
cytes [23]. Similarly, treatment of primary esophageal
keratinocytes with LY294002 resulted in an overall
decrease in the number of basal keratinocytes and thick-
ness of the epithelium [41]. It has been suggested that
PI3-kinase becomes important upon commitment of
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Page 11 of 13keratinocytes to differentiation, initiating the process
and subsequently delivering the required survival signals
[24]. Based on the histology of our raft cultures, there
were no apoptotic cells that are typified by highly con-
dense and shrunken nuclei (Figure 7A). The thinning of
the epithelium appears to stem from a severely curtailed
proliferation. Hence, in organotypic raft culture systems,
p-PKB/AKT appears to correlate with squamous differ-
entiation and survival but not with proliferation, as is
also evident from the lack of co-localization between p-
PKB/AKT and Ki-67 (Figure 7). Also in a study by
Menges et al [10] p-AKT is seen in differentiated non-
proliferating BrdU negative cells. These observation are
also in line with previous studies showing that AKT
knock-out MEFs reduce BrdU incorporation by only 44-
61% [42], indicating that AKT is not indispensible for
proliferation, though the lack of it would slow down cell
cycle progression at G1-S. We hypothesize that the bal-
ance in the dual character of PI3-kinase/PKB/AKT sig-
nalling shifts during the process of HPV-induced
transformation towards tumor characteristics, rather
than differentiation.
Conclusions
We have demonstrated that activation of the PI3-kinase/
PKB/AKT pathway, in part resulting from increased
PIK3CA expression, is functionally involved in HPV-
mediated transformation in vitro. PIK3CA-mediated
PI3-kinase signalling appeared essential in regulating
proliferation, anchorage-independent growth, migration
and importantly viral oncogene expression required to
maintain the transformed phenotypes. Moreover,
PIK3CA expression and PI3-kinase signalling emerged
as critical regulators of epithelial growth and differentia-
tion in organotypic raft cultures of HPV-immortalized
cells. Hence, PIK3CA and/or the PI3-kinase/PKB/AKT
pathway may provide suitable targets for therapeutic
intervention in patients with HPV-induced carcinomas.
Additional material
Additional file 1: Figure S1. Phosporylated-PKB/AKT and total PKB/
AKT protein expression in HPV18-containing keratinocytes. Protein
lysates of HPV18-containing keratinocytes at passage 31 and passage 95
were analysed for p-PKB/AKT, PKB/AKT and actin protein expression by
Western blot analysis.
Additional file 2: Figure S2. PIK3CA, phosporylated-PKB/AKT and
total PKB/AKT protein expression in HPV16E6E7 containing
keratinocytes from a different donor. Lysates were analysed for
protein expression at passage 13 and passage 60 for PIK3CA, p-PKB/AKT,
PKB/AKT and actin.
Additional file 3: Figure S3. Migration assay of primary human
foreskin keratinocytes without and with PIK3CA silencing.
Representative pictures of migration assay performed with primary
keratinocytes (p5). Upper panel: cells transfected with non-targeting
siRNA pool, lower panel: cells transfected with siRNA pool against
PIK3CA. Pictures were taken immediately after scratch induction and 24
hours post-induction.
Additional file 4: Figure S4. Organotypic raft cultures of primary
human foreskin keratinocytes without and with PIK3CA silencing.
H&E staining showing raft culture morphology following transfection of
primary human foreskin keratinocytes (p3) with non-targeting siRNAs
(left) and siRNAs targeting PIK3CA (right).
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